Cargando…
Teaching an Old Molecule New Tricks: Drug Repositioning for Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is one of the most severe forms of inherited muscular dystrophies. The disease is caused by the lack of dystrophin, a structurally essential protein; hence, a definitive cure would necessarily have to pass through some form of gene and/or cell therapy. Cell- and gen...
Autores principales: | Vitiello, Libero, Tibaudo, Lucia, Pegoraro, Elena, Bello, Luca, Canton, Marcella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929176/ https://www.ncbi.nlm.nih.gov/pubmed/31801292 http://dx.doi.org/10.3390/ijms20236053 |
Ejemplares similares
-
Genetic diagnosis as a tool for personalized
treatment of Duchenne muscular dystrophy
por: Bello, Luca, et al.
Publicado: (2016) -
Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy
por: Ricci, Giulia, et al.
Publicado: (2022) -
The “Usual Suspects”: Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy
por: Bello, Luca, et al.
Publicado: (2019) -
Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients
por: Vitiello, Libero, et al.
Publicado: (2018) -
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015)